dihydroergotamine has been researched along with diazepam in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (42.86) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Angersbach, P; Babej, E; Bollmann, H; Glaser, A; Kolbe, M; Pieschl, D; Schulze, H; von Seck, P | 1 |
| Raskin, NH | 1 |
| Degen, J; Maier-Lenz, H | 1 |
| Cecener, G; Egeli, U; Tunca, B; Yilmazlar, T; Zorluoglu, A | 1 |
1 review(s) available for dihydroergotamine and diazepam
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for dihydroergotamine and diazepam
| Article | Year |
|---|---|
[Combined study of Silentan. Test of a headache remedy in general and clinical practice].
Topics: Adult; Aspirin; Caffeine; Clinical Trials as Topic; Diazepam; Dihydroergotamine; Double-Blind Method; Drug Combinations; Female; Headache; Humans; Male; Middle Aged | 1979 |
Repetitive intravenous dihydroergotamine as therapy for intractable migraine.
Topics: Adult; Aged; Chronic Disease; Clinical Trials as Topic; Diazepam; Dihydroergotamine; Female; Humans; Injections; Injections, Intravenous; Male; Middle Aged; Migraine Disorders; Suppositories; Time Factors | 1986 |
4 other study(ies) available for dihydroergotamine and diazepam
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
[Comparative pharmacokinetics and relative bioavailability of the active principles diazepam, acetylsalicylic acid, caffeine, and dihydroergotamine tartrate in a combination product].
Topics: Adult; Aspirin; Biological Availability; Caffeine; Diazepam; Dihydroergotamine; Drug Combinations; Humans; Kinetics; Male | 1982 |
The mutation spectrum of the APC gene in Turkish patients with familial adenomatous polyposis.
Topics: Adenomatous Polyposis Coli; Aspirin; Biomarkers, Tumor; Caffeine; Diazepam; Dihydroergotamine; Drug Combinations; Gene Deletion; Genes, APC; Heteroduplex Analysis; Humans; Pedigree; Sequence Analysis, DNA; Turkey | 2007 |